YC W20
Algen Biotechnologies
Using CRISPR to find treatments for cancer and inflammation
About
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
Founders
- Chun-Hao Huang
- Christine Du
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Algen Biotechnologies.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliveryAI-powered Drug DiscoveryCRISPR